114 completed, 5 active not recruiting, 2 unknown, 2 withdrawn. 125 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 125 | Completed 114, Active not recruiting 5, Unknown 2, Withdrawn 2, Not yet recruiting 1, Terminated 1 |
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
Follow Corynebacterium Infections: new trials by email Literature Review of Corynebacterium Infections trials Research Report on Corynebacterium Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of BK1803 in Healthy Infants BK1803, GOBIK Aqueous Suspension Syringes, Bimmugen® Injection - Pertussis, Diphtheria | Phase 3 | Not yet recruiting | Tanabe Pharma Corporation | 344 | 2026-10-01 | 2026-08-28 |
| A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women dTpa - Diphtheria-Tetanus-acellular Pertussis Vaccines | Phase 3 | Active not recruiting | GlaxoSmithKline | 102 | 2026-06-29 | 2026-09-08 |
| A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series LBVD, Pentavalent vaccine and Inactivated Polio vaccine - Diphtheria, Tetanus | Phase 2 / Phase 3 | Active not recruiting | LG Chem | 1186 | 2025-05-30 | 2026-09-03 |
| Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 1), Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 2), Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 3) - Diphtheria, Tetanus and Acellular Pertussis | Phase 3 | Active not recruiting | CanSino Biologics Inc. | 780 | 2025-03-23 | 2025-08-15 |
| A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp)), 23-valent Pneumococcal Polysaccharide Vaccine (PPV23), Tdcp - Diphtheria, Tetanus | Phase 2 / Phase 3 | Completed | CanSino Biologics Inc. | 1820 | 2024-12-20 | 2026-08-26 |
| A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP), Diphtheria，Tetanus and Acellular Pertussis Combined Vaccine，DTaP, Diphtheria,tetanus,pertussis(acellular,component),Inactivated polio vaccine(adsorbed）and Haemophilus influenzae type b conjugate vaccine,adsorbed,DTaP-IPV-Hib - Diphtheria, Tetanus and Acellular Pertussis | Phase 3 | Active not recruiting | CanSino Biologics Inc. | 2520 | 2023-08-11 | 2025-03-17 |
| Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria. Clodivac, Td-Impfstoff Merieux - Diphtheria, Tetanus | Phase 3 | Unknown | IBSS Biomed S.A. | 200 | 2022-12-12 | 2024-02-05 |
| A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed, Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed, Diphtheria,tetanus,pertussis(acellular,component),poliomyelitis(inactivated) vaccine(absorbed) and Haemophilus influenzae type b conjugate vaccine - Whooping Cough, Diphtheria | Phase 3 | Active not recruiting | China National Biotec Group Company Limited | 2898 | 2021-10-22 | 2025-09-15 |
| Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed), Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed) - Streptococcus Pneumoniae Infections | Phase 3 | Completed | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 1110 | 2021-09-16 | 2025-02-10 |
| To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years DTaP-IPV combination vaccine - Diphtheria, Tetanus | Phase 3 | Unknown | Boryung Biopharma Co., Ltd. | 249 | 2019-12-26 | 2020-11-06 |
| Confirmatory Study of BK1310 in Healthy Infants DPT-IPV-Hib, Hib vaccine, DPT-IPV - Tetanus, Diphtheria | Phase 3 | Completed | Tanabe Pharma Corporation | 267 | 2019-04-01 | 2026-01-06 |
| Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series LBVD (Hexavalent vaccine), Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains) - Diphtheria, Tetanus | Phase 2 / Phase 3 | Completed | LG Chem | 60 | 2018-07-18 | 2026-09-03 |
| Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects Boostrix - Diphtheria-Tetanus-acellular Pertussis Vaccines | Phase 3 | Completed | GlaxoSmithKline | 448 | 2018-01-26 | 2020-10-27 |
| Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants Infanrix-IPV/Hib - Diphtheria, Acellular Pertussis | Phase 3 | Withdrawn | GlaxoSmithKline | 2017-12-01 | 2017-12-26 | |
| To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children BR-TD-1001, Td-pur inj - Diphtheria, Tetanus | Phase 3 | Completed | Boryung Biopharma Co., Ltd. | 218 | 2016-10-20 | 2020-11-20 |
| A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia Infanrix-IPV/Hib - Diphtheria, Tetanus | Phase 3 | Completed | GlaxoSmithKline | 235 | 2016-09-13 | 2019-09-24 |
| DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine - Diphtheria, Tetanus | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 53 | 2016-07-14 | 2022-04-05 |
| Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth Hexaxim® - Diphtheria, Tetanus | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 354 | 2015-04-20 | 2022-04-05 |
| Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS DTaP-IPV combination vaccine, DTaP vaccine and IPV vaccine - Diphtheria, Tetanus | Phase 3 | Completed | Boryung Pharmaceutical Co., Ltd | 476 | 2015-02-02 | 2023-06-28 |
| DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants DTaP-IPV/Hib Combined vaccine, DTaP-IPV vaccine and Hib vaccine - Tetanus, Diphtheria | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 424 | 2014-10-01 | 2022-04-25 |
Showing 20 of 125. Sign in to see all of them.
Diphtheria (125) · Tetanus (121) · Whooping Cough (77) · Poliomyelitis (64) · Haemophilus Infections (62) · Hepatitis B (57) · Virus Diseases (6) · Bacterial Infections (4) · Influenza, Human (4) · Meningococcal Infections (3) · Pneumococcal Infections (3) · Measles (2) · Meningitis, Bacterial (2) · Neoplasms, Glandular and Epithelial (2) · Acquired Immunodeficiency Syndrome (1)
Actinomycetales Infections (125) · Bacterial Infections and Mycoses (125) · Gram-Positive Bacterial Infections (125) · Infections (125) · Bacterial Infections (121) · Clostridium Infections (121) · Gram-Negative Bacterial Infections (99) · Virus Diseases (80) · Respiratory Tract Diseases (78) · Respiratory Tract Infections (78) · Bordetella Infections (77) · RNA Virus Infections (67) · Nervous System Diseases (66) · Neuroinflammatory Diseases (66)
Tetanus Toxoid (24) · Diphtheria-Tetanus-acellular Pertussis Vaccines (17) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (17) · Boostrix (13) · DTaP-IPV-HB-PRP-T vaccine (9) · Hiberix (9) · Pentavac (8) · Heptavalent Pneumococcal Conjugate Vaccine (7) · Vaccines, Combined (7) · adacel (7) · pentacel (6) · Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (5) · HibTITER protein, Haemophilus influenzae (5) · 13-valent pneumococcal vaccine (4) · Hepatitis B Vaccines (4)
GlaxoSmithKline (54) · Sanofi Pasteur, a Sanofi Company (34) · Sanofi (10) · Merck Sharp & Dohme LLC (7) · CanSino Biologics Inc. (3) · Tanabe Pharma Corporation (3) · Boryung Biopharma Co., Ltd. (2) · Crucell Holland BV (2) · LG Chem (2) · MCM Vaccines B.V. (2) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (1) · Boryung Pharmaceutical Co., Ltd (1) · China National Biotec Group Company Limited (1) · Heinrich-Heine University, Duesseldorf (1) · IBSS Biomed S.A. (1)
China (16) · United States (15) · Philippines (10) · South Korea (10) · Germany (8) · Thailand (8) · India (6) · Japan (6) · Vietnam (5) · France (4) · Russia (4) · South Africa (4) · Colombia (3) · Costa Rica (3) · Dominican Republic (3)
Anne Fiquet, MD (1) · Byeonguk Eun (1) · Dagmar Dilloo, MD, PhD (1) · Edison Alberto, MD (1) · HJ Jung (1) · Hanqing He (1) · Jong Hyun Kim (1) · Josefina Carlos, MD (1) · Lili Huang (1)
PMID 17716936, PMID 15882526, PMID 17090650, PMID 19095033, PMID 19117896, PMID 19952980, PMID 20439595, PMID 20950456, PMID 21219984, PMID 21289531, PMID 21334243, PMID 21441781, PMID 21807056, PMID 21945698, PMID 22001281, PMID 22157567, PMID 22273029, PMID 22349525, PMID 22475857, PMID 22531237, PMID 22691430, PMID 23783081, PMID 23966556, PMID 25765966, PMID 25882172, PMID 27288217, PMID 27510380, PMID 27846055, PMID 27846058, PMID 27879555, PMID 29576304, PMID 29789243, PMID 29960800, PMID 31307216, PMID 32048889, PMID 32307307, PMID 34931494, PMID 38582691, PMID 41276263, PMID 42483174
2015 (1), 2018 (1)